Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/3774
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShirwaikar, Annie-
dc.contributor.authorVerma, Renu-
dc.contributor.authorLobo, Richard-
dc.contributor.authorShirwaikar, Arun-
dc.date.accessioned2009-04-08T10:51:34Z-
dc.date.available2009-04-08T10:51:34Z-
dc.date.issued2009-02-
dc.identifier.issn0972-592X-
dc.identifier.urihttp://hdl.handle.net/123456789/3774-
dc.description55-63en_US
dc.description.abstractPlants have been used since ancient times as medicines for the treatment of a range of diseases. In spite of the great advances observed in modern medicine in recent decades, plants still make an important contribution to health care. According to the World Health Organization (WHO), because of poverty and lack of access to modern medicine, about 65-80% of the world’s population that are living in developing countries depend essentially on plants for primary health care. Phytotherapeutic agents are herbal preparations consisting of complex mixtures of one or more plants which contain active ingredients, plant parts or plant material in the crude or processed state. The data existing for most plants to guarantee their quality, efficacy and safety is insufficient. The concept that herbal drugs are safe and free from side effects is not always. Plants contain hundreds of constituents, some of which are very toxic namely the most cytotoxic anti-cancer plant-derived drugs is pyrrolizidine alkaloids, etc. However, the adverse effects of phytotherapeutic agents are less as compared with synthetic drugs. Several regulatory models for herbal medicines are currently available including prescription drugs, over-the-counter substances, traditional medicines and dietary supplements. Harmonization and improvement in the processes of regulation is needed for safety aspects related to phytotherapy.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.relation.ispartofseriesInt. cl.8— A61K 36/00en_US
dc.sourceNPR Vol.8(1) [January-February 2009]en_US
dc.subjectHerbsen_US
dc.subjectPhytotherapyen_US
dc.subjectHerbal safetyen_US
dc.subjectToxic constituentsen_US
dc.titlePhytotherapy–Safety aspectsen_US
dc.typeArticleen_US
Appears in Collections:NPR Vol.8(1) [January-February 2009]

Files in This Item:
File Description SizeFormat 
NPR 8(1) 55-63.pdf120.31 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.